This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Indian Renewable Energy Development Agency Limited has informed the Exchange regarding 'Audited Consolidated Financials for the period ended 31122025'.
IREDA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than Nifty Midcap 150 and 2.1 pts more than its Financial Institution peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
IREDA, a Government of India Navratna NBFC financing renewable energy projects, reported consolidated revenue from operations of ₹6,135 crore for the nine months ended 31 December 2025, up about 27% from ₹4,838 crore in the same period last year, driven by interest income rising to ₹6,042 crore from ₹4,714 crore. Profit after tax grew about 15% to ₹1,381 crore (from ₹1,197 crore), while EPS rose to ₹4.97 from ₹4.45. The loan book expanded sharply to ₹85,989 crore from ₹68,046 crore, with total assets reaching ₹92,200 crore. However, finance cost jumped to ₹3,664 crore from ₹3,037 crore, and impairment on financial instruments surged to ₹562 crore from ₹108 crore, which limited profit growth. Net cash flow from operations was deeply negative at (₹9,399 crore), which is normal for a growing NBFC disbursing loans. The auditor flagged two Emphasis of Matter items: (1) ₹400 crore of loans classified as Stage II/Standard instead of Stage III/NPA due to High Court interim orders, and (2) restatement of CRAR as at 31 December 2024 from 19.63% to 15.52% after the RBI-directed change in risk weights for renewable energy infrastructure assets from 50% to 100%.
Strong topline growth and continued loan book expansion signal healthy business momentum, but the sharp jump in impairment provisions and lower-than-expected PAT growth may weigh on near-term sentiment. The restated CRAR at 15.52% remains above regulatory thresholds but is materially lower than previously reported, and the ₹400 crore NPA-reclassification issue linked to court orders is a key watch item for asset quality.
| Q3 FY26 | Q3 FY25 | Change | |
|---|---|---|---|
| Revenue | ₹2,130 Cr | ₹1,698 Cr | +25.4% |
| Profit after tax | ₹584.9 Cr | ₹425.4 Cr | +37.5% |
From the company's XBRL filing, not from the text above. Operating profit and EBITDA margin are not shown for banks and lenders, whose other income is their business.